Published in:
01-06-2010 | Meeting Report
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008
Authors:
Michele Maio, Hugues J. M. Nicolay, Paolo A. Ascierto, Filippo Belardelli, Roberto Camerini, Mario P. Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Ester Fonsatti, Giorgio Parmiani, for the NIBIT
Published in:
Cancer Immunology, Immunotherapy
|
Issue 6/2010
Login to get access
Excerpt
The NIBIT (acronym for the Network Italiano per la Bioterapia dei Tumori—Italian Network for Tumor Biotherapy) was created in 2004 and given legal status as a non-profit association on September 2006. Among the scientific and operational goals of the NIBIT is to establish strong operative interactions with European and International cooperative Groups and Networks focussing their activities on cancer immuno-biotherapy. Along this line, during the sixth national annual meeting of the NIBIT, the ongoing contacts with different European bodies (i.e., Nordic Center of Excellence for the Development of anti-Tumor Vaccines, Sweden; German Network of Immunotherapy of Tumors, Germany; Biotherapy Development Association; European Society of Cancer Immunology and Immunotherapy) and with single scientific Institutions across Europe have been discussed. Aim of this project is to explore the possibility to setup a structured, global European Network of Cancer Immuno-Biotherapy Centers. …
